Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic virus that causes severe respiratory disease in humans with a case fatality rate close to 40%, but for which no vaccines are available. Here, we evaluated the utility of ChAdOx1, a promising replication-deficient simian aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Munster, Vincent J., Wells, Daniel, Lambe, Teresa, Wright, Daniel, Fischer, Robert J., Bushmaker, Trenton, Saturday, Greg, van Doremalen, Neeltje, Gilbert, Sarah C., de Wit, Emmie, Warimwe, George M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643297/
https://www.ncbi.nlm.nih.gov/pubmed/29263883
http://dx.doi.org/10.1038/s41541-017-0029-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643297/
https://www.ncbi.nlm.nih.gov/pubmed/29263883
http://dx.doi.org/10.1038/s41541-017-0029-1

Ejemplares similares